Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…Background Carotid artery stenosis is a major cause of stroke and is commonly treated with carotid…
…ground The impact of parent artery stenosis on the treatment of intracranial aneurysms by using flow diversion (FD) remains unknown. This multicenter …
…posure, high cost and limited access. The abbreviated MRI using gadoxetic acid versus multiphasic CECT for detection of late recurrent HCC aft…
…ectively). Time since last prescription was not associated with fragility fracture. After three and five years of bisphosphonate prescription, the…
…fter stroke. Patient characteristics at hospital admission (ie, National Institutes of Health Stroke Scale, modified Rankin Scale, age, sex and recanalisation therapy) we…
…Objective Neurogastroenterology disorders, including disorders of gut-brain interaction (DGBI), are among…
…5% (2.1% to 2.9%) in winter; 2.4% (1.8% to 3.0%) in summer) and digestive diseases (2.5% (1.6% to 3.3%) in winter; 2.6% (1.7% to 3.5%) in summer) …
…djustment for baseline imbalances, supporting ES as a high-risk SLE phenotype.…
…Background/objective To reduce the risk of hydroxychloroquine (HCQ)-induced retinopathy, the American Academy of Ophthalmolog…
…Demographics, mental health and substance use disorders (SUDs), antidepressant treatment, behavioural therapy and healthcare utilisation were compared a…
…age in terms of PFS, it has a high incremental cost compared to afatinib. Therefore, the treatment is not cost-effective based on the th…
…ns (3.6%), 20 irinotecan (2.0%), 196 paclitaxel (16.6%), and 21 trastuzumab (3.1%).Conclusion and Relevance A simulation analysis of a dose…